EPY0001148 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Budesonide for system suitability Continue ReadingEPY0001148
EPB1156000 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bufexamac Continue ReadingEPB1156000
EPY0001732 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bufexamac impurity A - 2-(4-Butoxyphenyl)acetamide Continue ReadingEPY0001732
EPY0001729 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bufexamac impurity A - 4-Butoxyphenylacetlc acid Continue ReadingEPY0001729
EPY0001730 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bufexamac impurity B - Methyl 2-(4-butoxyphenyl)acetate Continue ReadingEPY0001730
EPY0001731 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bufexamac impurity C - Butyl 2-(4-butoxyphenyl)acetate Continue ReadingEPY0001731
EPY0001529 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Buflomedil for peak identification Continue ReadingEPY0001529
EPB1157400 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Buflomedil hydrochloride Continue ReadingEPB1157400
EPB1157410 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Buflomedil impurity B - 4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one Continue ReadingEPB1157410
EPB1158000 Post author:adminlaboratory Post published:2022.06.09. Post category: Post comments:0 Comments Bumetanide Continue ReadingEPB1158000
